ZBHNEUTRAL

P/E Ratio

21.7x

Higher than 37% of Healthcare sector peers

Updated 1054h ago

Sector Performance

37th percentile

ZBH

21.7x

Sector Median

24.6x

Sector Avg

28.9x

📊

Deep Analysis

Zimmer Biomet Holdings, Inc. (ZBH) has a P/E Ratio of 21.7x as of May 2026.

This places ZBH in the 37th percentile of the Healthcare sector, which has a median P/E Ratio of 24.6x and a sector average of 28.9x. ZBH's P/E Ratio is 11.9% below the sector median. In context: Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Frequently Asked Questions

What does the P/E Ratio tell investors about ZBH?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

How does ZBH's P/E Ratio compare to its sector?

ZBH's P/E Ratio of 21.7x compares to a Healthcare sector median of 24.6x, placing it in the 37th percentile.

Who are ZBH's closest peers by P/E Ratio?

The closest Healthcare peers by P/E Ratio include: TMO (24.6x), AMGN (24.7x), BSX (25.8x), A (23.0x), AZN (27.0x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Master ZBH's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full ZBH research report

Free account — no credit card

ZBH

21.7x

Sector Median

24.6x

Sector Avg

28.9x

How ZBH's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.